ExlService (EXLS) vs HealthEquity (HQY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
HealthEquity (HQY) has outperformed ExlService (EXLS) over the past year, losing 0.2% versus a loss of 12.4%. Over five years, EXLS leads with a +48.2% price change compared with +46.7% for HQY. HealthEquity is the larger company by market cap ($7.66 billion vs $5.58 billion), about 1.4 times the size, while ExlService is growing revenue faster (+13.6% vs +9.5%).
On valuation, ExlService trades at a lower forward P/E (14.2x vs 16.8x for HealthEquity). HealthEquity converts more of its revenue into profit, with a net margin of 16.4% versus 12.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EXLS | HQY |
|---|---|---|
| Share price | $36.79 | $92.61 |
| Market cap | $5.58B | $7.66B |
| 1-day change | -0.22% | -0.47% |
| YTD return | -13.31% | +1.09% |
| 1-year return | -12.38% | -0.18% |
| 5-year return | +48.17% | +46.65% |
| P/E ratio (TTM) | 23.28 | 33.43 |
| Forward P/E | 14.17 | 16.84 |
| EPS (TTM) | $1.58 | $2.77 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $2.09B | $1.31B |
| Revenue growth (YoY) | +13.56% | +9.47% |
| Net income (latest FY) | $251.02M | $215.20M |
| Gross margin | 38.37% | 69.52% |
| Operating margin | 15.03% | 24.55% |
| Net margin | 12.02% | 16.38% |
| 52-week high | $43.88 | $107.62 |
| 52-week low | $24.85 | $72.76 |
| Distance from 52-week high | -16.16% | -13.95% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +21.31% | +28.85% |
| Average volume | 2.22M | 840.30K |
| Shares outstanding | 151.61M | 82.72M |
| Employees | 65,000 | 2,814 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Business Services | Business Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HQY has outperformed EXLS by 12.2 percentage points over the past year.
- HealthEquity trades at a higher earnings multiple (33.4x vs 23.3x trailing P/E).
About ExlService
EXLS stock →ExlService Holdings, Inc., operates as a data and artificial intelligence (AI) company in the North America, the United Kingdom, Europe, and internationally. The company operates through Insurance; Healthcare and Life Sciences; Banking, Capital Markets, and Diversified Industries; and International Growth Markets.
Consumer Discretionary · Business Services · 65,000 employees
About HealthEquity
HQY stock →HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States.
Consumer Discretionary · Business Services · 2,814 employees
EXLS vs HQY FAQ
Which is bigger, ExlService or HealthEquity?
HealthEquity (HQY) is larger, with a market capitalization of $7.66B compared with $5.58B for ExlService (EXLS).
Which stock has performed better over the past year, EXLS or HQY?
HQY returned -0.18% over the past 12 months, compared with -12.38% for EXLS (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, EXLS or HQY?
EXLS has the lower trailing P/E at 23.3, versus 33.4 for HQY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are ExlService and HealthEquity in the same industry?
Yes. Both are classified in the Business Services industry within the Consumer Discretionary sector.